Patent · US Active

Selective glycosidase inhibitors and uses thereof

US9120781B2 · kind B2 · utility

24Cited by
5References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 10, 2011
Grant dateSep 1, 2015
Priority date
Expiry dateMay 10, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.